These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 20392606)
1. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction. Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606 [TBL] [Abstract][Full Text] [Related]
2. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638 [TBL] [Abstract][Full Text] [Related]
3. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients. Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880 [TBL] [Abstract][Full Text] [Related]
4. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers. Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582 [TBL] [Abstract][Full Text] [Related]
6. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472 [TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction. Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Kobayashi T; Sadoh S; Morita K; Kamimura H; Karube Y J Infect Chemother; 2011 Feb; 17(1):70-5. PubMed ID: 20582446 [TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of linezolid. French G J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii45-53. PubMed ID: 12730142 [TBL] [Abstract][Full Text] [Related]
10. Renal function as a predictor of linezolid-induced thrombocytopenia. Matsumoto K; Takeda Y; Takeshita A; Fukunaga N; Shigemi A; Yaji K; Shimodozono Y; Yamada K; Ikawa K; Morikawa N Int J Antimicrob Agents; 2009 Jan; 33(1):98-9. PubMed ID: 18790615 [No Abstract] [Full Text] [Related]
11. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin. Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075 [TBL] [Abstract][Full Text] [Related]
13. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094 [TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients. Hirano R; Sakamoto Y; Tachibana N; Ohnishi M Int J Clin Pharm; 2014 Aug; 36(4):795-9. PubMed ID: 24913359 [TBL] [Abstract][Full Text] [Related]
15. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries. Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078 [TBL] [Abstract][Full Text] [Related]
17. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries]. Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590 [TBL] [Abstract][Full Text] [Related]
19. Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid. Soriano A; Ortega M; García S; Peñarroja G; Bové A; Marcos M; Martínez JC; Martínez JA; Mensa J Antimicrob Agents Chemother; 2007 Jul; 51(7):2559-63. PubMed ID: 17470658 [TBL] [Abstract][Full Text] [Related]